Casandra
Casandra Test Code QD24722Version 1 (DRAFT)
Performing Lab
Acute Myeloid Leukemia Prognostic Panel (Normal Karyotype)
Clinical Use
Order TestUse
Not provided.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS (Targeted)
Biomarkers
CEBPA, NPM1, FLT3
GeneSNV/Indel
Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
5 mL
Minimum Volume
3 mL
Container
EDTA (lavender-top) tube
Collection Instructions
Collect 3-5 mL whole blood samples in an EDTA tube.
Similar Tests
Other tests from different labs that may be relevant
Acute Myeloid Leukemia Mutation Panel by Next Generation Sequencing
ARUP Laboratories
Rapid Acute Myeloid Leukemia Targeted Therapy Mutation Panel
ARUP Laboratories
CEBPA Mutation Analysis
NeoGenomics
Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing
ARUP Laboratories
NeoTYPE® AML Prognostic Profile
NeoGenomics
CEBPA Mutation Analysis
Labcorp
MayoComplete Acute Myeloid Leukemia, 11-Gene Panel, Varies
Mayo Clinic Lab
Myeloid Malignancies Mutation Panel by Next Generation Sequencing
ARUP Laboratories
Rapid AML Therapeutic Panel
NeoGenomics
NPM1 Mutation Analysis
Labcorp